Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CUR > SEC Filings for CUR > Form 8-K on 22-Apr-2013All Recent SEC Filings

Show all filings for NEURALSTEM, INC. | Request a Trial to NEW EDGAR Online Pro



Other Events, Financial Statements and Exhibits

Item 8.01. Other Events.

On April 17, 2013, Neuralstem, Inc. ("Company") announced that it received approval from the United States Food and Drug Administration ("FDA") to commence a Phase II clinical trial using NSI-566 in the treatment of amyotrophic lateral sclerosis or ALS. A copy of the press release is attached to this report as Exhibit 99.01.

On April 18, 2013, the Company announced that CEO and President, Richard Garr, will take part in a comprehensive Bio Maryland panel at the BIO International Convention in Chicago, Ill on April 24, 2013. A copy of the press release is attached to this report as Exhibit 99.02.

On April 22, 2013, the Company announced that it received approval from the FDA to begin dosing the third and final cohort of patients in the Company's ongoing Phase Ib clinical trial to test the safety of NSI-189 in the treatment of major depressive disorder. A copy of the press release is attached to this report as Exhibit 99.03.

Item 9.01 Financial Statement and Exhibits.

Exhibit Number   Description

99.01            Press Release Dated April 17, 2013
99.02            Press Release Dated April 18, 2013
99.03            Press Release Dated April 22, 2013

  Add CUR to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CUR - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.